We are live on
!
Find out more
GCL
Glazer Capital LLC Portfolio holdings
AUM
$4.71B
1-Year Est. Return
81.93%
This Fund
S&P 500
This Quarter
Est. Return
+18.9%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.8B
AUM Growth
+$824M
(+28%)
Cap. Flow
+$356M
Cap. Flow
% of AUM
9.35%
Top 10 Holdings %
Top 10 Hldgs %
43.5%
Holding
460
New
148
Increased
43
Reduced
126
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DAY
Dayforce
DAY
|
+$273M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$159M |
| 3 |
AL
Air Lease Corp
AL
|
+$143M |
| 4 |
CMA
Comerica
CMA
|
+$140M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRNA
Verona Pharma
VRNA
|
+$342M |
| 2 |
MRUS
Merus
MRUS
|
+$152M |
| 3 |
COOP
Mr. Cooper
COOP
|
+$123M |
| 4 |
AVDX
AvidXchange
AVDX
|
+$85.1M |
| 5 |
ETNB
89bio
ETNB
|
+$82.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.45% |
| 2 | Technology | 18.96% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 6.99% |
| 5 | Communication Services | 4.55% |
Similar funds
GCM
KCM
SCB
AA
RS
VDI
DCP
CCWM
Glazer Capital LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Glazer Capital LLC held 460 positions worth $3.8B, up 28% from $2.98B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Glazer Capital LLC deployed $356M of net new capital in Q4 2025, opening 148 new positions and adding to 43 existing holdings. Its largest new stake was Avidity Biosciences: 2,467,139 shares worth $178M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was ProAssurance, an estimated $19M trimmed.
- Glazer Capital LLC's largest Q4 2025 buy was Avidity Biosciences: 2,467,139 shares worth $178M.
- Glazer Capital LLC added most to Dayforce in Q4 2025, an estimated $273M increase.
- Glazer Capital LLC's biggest Q4 2025 reduction was ProAssurance, cutting an estimated $19M.
- Glazer Capital LLC fully exited Verona Pharma in Q4 2025, selling an estimated $342M.
- Glazer Capital LLC's ten largest holdings make up 44% of its $3.8B portfolio in Q4 2025.
- Glazer Capital LLC opened 148 new positions and closed 97 in Q4 2025.
- Glazer Capital LLC's portfolio value rose 28% quarter-over-quarter to $3.8B.
Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.